SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABT: Abbott Laboratories
ABT 124.51-1.7%3:59 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: HerbVic8/11/2004 12:10:35 PM
   of 33
 
Abbott Laboratories Introduces First Fully Automated Test for Hepatitis A Virus

-AxSYM(R) HAVAB-M(TM) 2.0 Assay Detects the IgM Antibody to Hepatitis A
Providing Diagnostic Laboratories With a Simple and Convenient Test-

LOS ANGELES, July 27 /PRNewswire-FirstCall/ -- Today at the annual meeting
of the American Association of Clinical Chemistry (AACC), Abbott Laboratories
introduced the first fully automated hepatitis A assay in the United States
for its widely used AxSYM(R) automated immunoassay instrument system. Used to
diagnose an acute or recent hepatitis A viral infection, the AxSYM(R) HAVAB-
M(TM) 2.0 assay detects the IgM antibody to hepatitis A (IgM anti-HAV).
Abbott will be introducing additional AxSYM hepatitis assays in the United
States throughout 2004 and continuing into 2005.

<snip>

prnewswire.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News